0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

From the Centers for Disease Control and Prevention |  April 03, 2013 FREE
Thrombotic Thrombocytopenic Purpura (TTP)–Like Illness Associated With Intravenous Opana ER Abuse—Tennessee, 2012
JAMA. 2013;309(13):1338-1340. doi:10.1001/jama.2013.357.
From the Centers for Disease Control and Prevention |  January 23, 2013
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
JAMA. 2013;309(4):334-336. doi:10.1001/jama.2012.31377.
JAMA Patient Page |  January 02, 2013 FREE
Severe Combined Immunodeficiency
Ann R. Punnoose, MD; Cassio Lynm, MA; Robert M. Golub, MD
JAMA. 2013;309(1):98. doi:10.1001/jama.2012.6226.
INCLUDES: , Supplemental Content
JAMA Patient Page |  February 15, 2012 FREE
Henoch-Schönlein Purpura
Ann R. Punnoose, MD; Cassio Lynm, MA; Robert M. Golub, MD
JAMA. 2012;307(7):742. doi:10.1001/jama.2012.81.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  December 14, 2011
FDA Grants Approval for First Cord Blood Product
Rebecca Voelker
JAMA. 2011;306(22):2442. doi:10.1001/jama.2011.1759.
Grand Rounds |  December 01, 2010
Multiple Myeloma Precursor Disease
Ola Landgren, MD, PhD; Adam Justin Waxman, BA
JAMA. 2010;304(21):2397-2404. doi:10.1001/jama.2010.1713.
INCLUDES: CME
Commentary |  November 17, 2010
Accelerated Approval and Possible Withdrawal of Midodrine
Sanket S. Dhruva, MD; Rita F. Redberg, MD, MSc
JAMA. 2010;304(19):2172-2173. doi:10.1001/jama.2010.1695.
Medical News and Perspectives |  September 22, 2010
Troubled by “Stem Cell Tourism” Claims, Group Launches Web-Based Guidance
Mike Mitka
JAMA. 2010;304(12):1315-1316. doi:10.1001/jama.2010.1329.
From the Centers for Disease Control and Prevention |  September 08, 2010 FREE
Addition of Severe Combined Immunodeficiency as a Contraindication for Administration of Rotavirus Vaccine
JAMA. 2010;304(10):1064-1067. doi:.
Medical News and Perspectives |  January 24, 2007
Agents to Control Bleeding Show Promise
JAMA. 2007;297(4):349-353. doi:10.1001/jama.297.4.349.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Related JAMA Topics
From The JAMA Network
JAMA Neurology
Observation  |  February 25, 2013
IgG4-Related Neuropathy:  A Case Report
Ken Ohyama, MD; Haruki Koike, MD, PhD; Masahiro Iijima, MD, PhD; et al.
JAMA Neurology
Research Letters  |  April 01, 2013
Month of Birth and Thymic Output
Giulio Disanto, MD; Corey T. Watson, PhD; Ute C. Meier, DPhil; et al.
JAMA Psychiatry
Original Article  |  Mar 2013
Increased Prevalence of Diverse N -Methyl-D-Aspartate Glutamate Receptor Antibodies in Patients With an Initial Diagnosis of Schizophrenia:  Specific Relevance of IgG NR1a Antibodies for Distinction From N -Methyl-D-Aspartate Glutamate Receptor Encephalitis
Johann Steiner, MD; Martin Walter, MD; Wenzel Glanz, MD; et al.
JAMA Neurology
Original Contribution  |  Oct 2012
Fingolimod Impedes Schwann Cell–Mediated Myelination:  Implications for the Treatment of Immune Neuropathies?
Angelika Köhne, MD; Mark Stettner, MD; Parastoo Jangouk, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems